DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 26 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217 | -93.0% | 84 | -95.9% | 0.00% | – |
| Q1 2023 | $3,118 | -47.5% | 2,038 | -45.8% | 0.00% | – |
| Q4 2022 | $5,936 | -34.0% | 3,757 | -47.8% | 0.00% | – |
| Q3 2022 | $9,000 | +50.0% | 7,191 | +137.3% | 0.00% | – |
| Q2 2022 | $6,000 | +200.0% | 3,030 | +218.9% | 0.00% | – |
| Q1 2022 | $2,000 | -88.2% | 950 | -79.4% | 0.00% | – |
| Q4 2021 | $17,000 | -81.5% | 4,618 | -77.7% | 0.00% | – |
| Q2 2021 | $92,000 | +820.0% | 20,715 | +1872.9% | 0.00% | – |
| Q1 2021 | $10,000 | +11.1% | 1,050 | +14.9% | 0.00% | – |
| Q4 2020 | $9,000 | +125.0% | 914 | +55.2% | 0.00% | – |
| Q2 2020 | $4,000 | -83.3% | 589 | -93.1% | 0.00% | – |
| Q1 2020 | $24,000 | +380.0% | 8,500 | +261.1% | 0.00% | – |
| Q3 2019 | $5,000 | -54.5% | 2,354 | +4.6% | 0.00% | – |
| Q2 2019 | $11,000 | +175.0% | 2,250 | +70.1% | 0.00% | – |
| Q4 2018 | $4,000 | – | 1,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |